Physician profile
Thomas Gerald Chu
NPI 1760482806
$2,701.19
in general payments reported to CMS, 2019-2025
10 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $431 · 2020: $137 · 2021: $671 · 2022: $431 · 2023: $545 · 2024: $332 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,032.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,031.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $990.14 | 2019-2025 | Constellation, Unity |
| Regeneron Healthcare Solutions, INC. | $728.64 | 2019-2023 | Eylea |
| Genentech USA, INC. | $292.45 | 2019-2025 | Vabysmo |
| Abbvie INC. | $250.51 | 2022-2025 | Ozurdex |
| Janssen Biotech, INC. | $120.62 | 2021 | |
| Sandoz INC. | $93.18 | 2024 | Cimerli |
| Mallinckrodt Hospital Products INC. | $92.99 | 2021 | |
| Allergan, INC. | $84.64 | 2020-2021 | |
| Apellis Pharmaceuticals, INC. | $48.02 | 2022-2023 | Syfovre |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Chu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.